ClinicalTrials.gg
RecruitingNCT06546176Updated Aug 9, 2024

End to End Anastomosis With Omega Suture Versus End to Anterior Rectal Wall In Colorectal Anastomosis in Sigmoid and Upper Rectal Cancer

An interventional study of End to end with Omega suture and End to anterior rectal wall in End to End Anastomosis, Colorectal Anastomosis and End to Anterior Rectal Wall, sponsored by Ain Shams University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-08-09.

Sponsored by Ain Shams University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years 2 months ago, but the record still lists the study as recruiting.
  • Registered 11 months after the study started (first participant enrolled Sep 2023, registered Aug 2024).
  • Started Sep 2023; still recruiting 3 years 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to compare end to end anastomosis with omega suture versus end to anterior rectal wall in colorectal anastomosis as regard post operative anastomotic leakage, bowel function, operative time and intra operative blood loss.

Read the detailed description

Colorectal cancer has been reported to be the 3rd most common and the second most deadly cancer world wide.

Anterior resection is the gold standard operation for both rectal and recto-sigmoid cancer with considering oncological safety maintenance to be the most important goal which can be achieved by keeping abundant resection margin and ensuring anastomotic safety, despite the technical difficulties of working in a narrow deep pelvis.

Understanding the characteristics of each anastomotic technique and establishing a stable anastomotic procedure both are pillars in anastomotic leakage prevention.

The intersection of the linear staple line and circular staple line in conventional anastomotic way is considered a risk factor for anastomotic leakage by creating stapled corners (called "dog-ears") which considered potentially ischemic and represent the area with high incidence of anastomotic leakage. Single stapled technique using ether end to end with omega suture or end to side stapled anastomosis allows avoidance of the formation of this intersection.

02

Conditions studied

  • End to End Anastomosis
  • Colorectal Anastomosis
  • End to Anterior Rectal Wall
  • Sigmoid Cancer
  • Upper Rectal Cancer
03

In context

Sigmoid Neoplasms

20 studies on the registry are indexed under Sigmoid Neoplasms; 5 are open to participants now.

This study's planned enrollment of 40 is below the median of 55 across 14 interventional studies indexed under Sigmoid Neoplasms.

Browse Sigmoid Neoplasms studies →

Lead sponsor

Ain Shams University is the lead sponsor of 1,950 studies on the registry; 429 are open to participants now.

Of its 35 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged >18 years.
  • Both sexes.
  • Recto sigmoidal carcinoma.
  • Upper rectal cancer.

Exclusion criteria

Exclusion Criteria:

  • Patients younger than 18 years
  • Recurrent or non-resectable cancer
  • Complicated cancer (e.g., obstructed or perforated)
  • Previous left-sided colorectal surgery or anorectal surgeries
  • Lower rectal cancer
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Other
    Group A(end to end with Omega suture)

    After the rectum was divided with a linear stapler, the circular stapler was placed allowing the anvil rod to penetrate the rectal stump near the linear stapler line. An omega suture including both ends of the linear stapler line was placed. The linear stapler line was approximated around the anvil rod of the circular stapler in an omega shape fashion as the omega suture was tied. This technique resulted in a complete resection of linear stapler line by the circular stapler.

    Other: End to end with Omega suture

  • Other
    Group B (end to anterior rectal wall)

    A burse string suture was applied over the anvil of the circular stapler at the transection point of the descending colon using prolene 2/0. The circular stapler introduced though the anus and its rod directed toward the anterior rectal wall and colorectal anastomosis was performed.

    Other: End to anterior rectal wall

Interventions

  • OtherEnd to end with Omega suture

    After the rectum was divided with a linear stapler, the circular stapler was placed allowing the anvil rod to penetrate the rectal stump near the linear stapler line. An omega suture including both ends of the linear stapler line was placed. The linear stapler line was approximated around the anvil rod of the circular stapler in an omega shape fashion as the omega suture was tied. This technique resulted in a complete resection of linear stapler line by the circular stapler.

  • OtherEnd to anterior rectal wall

    A burse string suture was applied over the anvil of the circular stapler at the transection point of the descending colon using prolene 2/0. The circular stapler introduced though the anus and its rod directed toward the anterior rectal wall and colorectal anastomosis was performed.

06

What researchers measure

Primary outcomes

  1. Anastomotic leakage

    Anastomotic leakage will be measured for 5 days after surgery

    Time frame: 5 days after surgery

Secondary outcomes

  1. Operative time

    Operative time will be measured from the start of surgery till the end of surgery.

    Time frame: Until the procedure is completed

  2. Hospital stay

    Hospital stay will be assessed from admission till discharge from hospital

    Time frame: 28 days postoperative

  3. Time of bowel function

    Time of bowel function will be assessed

    Time frame: 7 days postoperative

  4. Wound complications

    Wound complications will be recorded as bleeding and infection.

    Time frame: 7 days postoperative

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Supporting information: Study protocol

Time frame: After the end of study for one year.

Access criteria: The data will be available upon a reasonable request from the corresponding author.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06546176
Responsible party
Asmaa fathi (Assistant Lecturer of General Surgery, Ain Shams University, Ain Shams University) — Principal investigator
First posted
Aug 9, 2024
Start date
Sep 1, 2023
Primary completion
Sep 1, 2024 (estimated)
Completion
Sep 1, 2024 (estimated)
Last update
Aug 9, 2024

Study contacts

Asmaa F Hussein, Master
Contact
asmaafathi@med.asu.edu.eg
00201009376712

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion